|
|
Volumn 9, Issue 9, 2003, Pages 1100-1101
|
|
Technologies that deliver
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANGINA PECTORIS AGENT;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
CARMUSTINE;
CONTRACEPTIVE AGENT;
ESTROGEN;
ETHINYLESTRADIOL PLUS NORELGESTROMIN;
GANCICLOVIR;
GESTAGEN;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
LIDOCAINE;
LOCAL ANESTHETIC AGENT;
NIFEDIPINE;
RAPAMYCIN;
UNCLASSIFIED DRUG;
VIRUS VECTOR;
ANGINA PECTORIS;
CANCER CHEMOTHERAPY;
CANCER THERAPY;
CLINICAL TRIAL;
COMBINED IMMUNODEFICIENCY;
CORONARY STENT;
CYSTIC FIBROSIS;
DIABETES MELLITUS;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG IMPLANT;
ELECTRIC CURRENT;
EMPHYSEMA;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
GLIOMA;
HEMOPHILIA;
HEPATITIS C;
HORMONAL CONTRACEPTION;
HUMAN;
INHALER;
INSULIN TREATMENT;
LEUKEMIA;
MEDICAL TECHNOLOGY;
MIGRAINE;
PARKINSON DISEASE;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
SHORT SURVEY;
SUSTAINED RELEASE PREPARATION;
TABLET FORMULATION;
TECHNOLOGY;
UVEITIS;
VIRAL GENE THERAPY;
CLINICAL TRIALS;
DRUG ADMINISTRATION ROUTES;
DRUG APPROVAL;
DRUG DELIVERY SYSTEMS;
GENE THERAPY;
HUMANS;
INSULIN;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
HEPATITIS C VIRUS;
|
|
EID: 0141625692
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0903-1100 Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|